Home
ANVS
ANVS News

Latest Annovis Bio Inc. (ANVS) News on February 23, 2025

Annovis to Host Patients’ Live Forum on February 27, 2025

GlobeNewswire

4 days ago

Annovis to Host Patients’ Live Forum on February 27, 2025

Annovis to Present at Oppenheimer's 35th Annual Healthcare Life Sciences Conference

GlobeNewswire

16 days ago

Annovis to Present at Oppenheimer's 35th Annual Healthcare Life Sciences Conference

Annovis begins treatment of subjects in Alzheimer’s trial

Clinical Trials Arena

17 days ago

Annovis begins treatment of subjects in Alzheimer’s trial

Annovis Bio announces first patients entered Phase 3 study of buntanetap

TipRanks

17 days ago

Annovis Bio announces first patients entered Phase 3 study of buntanetap

MT Newswires

18 days ago

Annovis Bio Enrolls First Patients in Phase 3 Trial of Buntanetap for Early Alzheimer's Disease

Annovis Announces First Patients Entered into Pivotal Phase 3 Study of Buntanetap for Early Alzheimer’s Disease

GlobeNewswire

18 days ago

Annovis Announces First Patients Entered into Pivotal Phase 3 Study of Buntanetap for Early Alzheimer’s Disease

Annovis Bio, Inc. Announces Closing of $21 Million Public Offering

GlobeNewswire

18 days ago

Annovis Bio, Inc. Announces Closing of $21 Million Public Offering

MT Newswires

19 days ago

Top Midday Decliners

MT Newswires

20 days ago

Annovis Bio Prices $21 Million Public Offering; Shares Fall Sharply

MT Newswires

20 days ago

Top Premarket Decliners

Annovis Bio, Inc. Announces Pricing of $21 Million Public Offering

GlobeNewswire

20 days ago

Annovis Bio, Inc. Announces Pricing of $21 Million Public Offering

Annovis Bio, Inc. Announces Proposed Public Offering

GlobeNewswire

22 days ago

Annovis Bio, Inc. Announces Proposed Public Offering

Annovis Bio granted U.S. patent covering buntanetap

TipRanks

a month ago

Annovis Bio granted U.S. patent covering buntanetap

MT Newswires

a month ago

Annovis Bio Receives US Patent for Treating Acute Brain, Nerve Injuries With Buntanetap

Annovis Granted U.S. Patent for Treatment and Prevention of Acute Brain or Nerve Injuries Securing Global Protection

GlobeNewswire

a month ago

Annovis Granted U.S. Patent for Treatment and Prevention of Acute Brain or Nerve Injuries Securing Global Protection

MT Newswires

2 months ago

Annovis Bio Says FDA Approved Revised Protocol for Phase 3 Alzheimer's Disease Study

FDA Accepts Final Protocol for Pivotal Phase 3 Alzheimer’s Disease Study, Streamlining Development Pathway

GlobeNewswire

2 months ago

FDA Accepts Final Protocol for Pivotal Phase 3 Alzheimer’s Disease Study, Streamlining Development Pathway

Annovis CEO Showcases Groundbreaking Advances in Neurodegenerative Disease Treatment on Today’s Marketplace

GlobeNewswire

3 months ago

Annovis CEO Showcases Groundbreaking Advances in Neurodegenerative Disease Treatment on Today’s Marketplace

Annovis to Host Year-End Investor Webcast on December 11, 2024

GlobeNewswire

3 months ago

Annovis to Host Year-End Investor Webcast on December 11, 2024

Annovis Invited to Present at National Institute on Aging Workshop on Dementia with Lewy Bodies (DLB)

GlobeNewswire

3 months ago

Annovis Invited to Present at National Institute on Aging Workshop on Dementia with Lewy Bodies (DLB)

Annovis Bio Reports Third Quarter Financial Results and Provides Business Update

GlobeNewswire

3 months ago

Annovis Bio Reports Third Quarter Financial Results and Provides Business Update

Will Annovis Bio (NYSE:ANVS) Spend Its Cash Wisely?

Simply Wall St.

3 months ago

Will Annovis Bio (NYSE:ANVS) Spend Its Cash Wisely?

Annovis Bio Appoints Matthew Peterson, Ph.D., as Senior Clinical Scientist

GlobeNewswire

4 months ago

Annovis Bio Appoints Matthew Peterson, Ph.D., as Senior Clinical Scientist

IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Maria Maccecchini, CEO of Annovis Bio

GlobeNewswire

4 months ago

IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Maria Maccecchini, CEO of Annovis Bio

MT Newswires

4 months ago

Maxim Upgrades Annovis Bio to Buy From Hold, Price Target is $25

Annovis to Highlight Buntanetap's Alzheimer's Research Progress with Presentations at CTAD 2024

GlobeNewswire

4 months ago

Annovis to Highlight Buntanetap's Alzheimer's Research Progress with Presentations at CTAD 2024

Annovis Bio Shows Promise on FDA Clearance for Alzheimer's Drug

GuruFocus.com

4 months ago

Annovis Bio Shows Promise on FDA Clearance for Alzheimer's Drug

FDA Clears Annovis to Launch Pivotal Phase 3 Alzheimer’s Studies, Paving the Way to NDAs

GlobeNewswire

4 months ago

FDA Clears Annovis to Launch Pivotal Phase 3 Alzheimer’s Studies, Paving the Way to NDAs

Annovis Bio Inc. (NYSE: ANVS) Leading Way in Development of Safe, Effective Drugs for Neurodegenerative Diseases

GlobeNewswire

5 months ago

Annovis Bio Inc. (NYSE: ANVS) Leading Way in Development of Safe, Effective Drugs for Neurodegenerative Diseases

Annovis Bio Inc. (NYSE: ANVS) Research Points to Potential Future Breakthroughs in AD Space Through Innovative Combinations

GlobeNewswire

5 months ago

Annovis Bio Inc. (NYSE: ANVS) Research Points to Potential Future Breakthroughs in AD Space Through Innovative Combinations

MT Newswires

5 months ago

Annovis Bio Files Patents for Combination Therapies Using Buntanetap

Annovis Files Three New Patents for Combination Therapies Involving Buntanetap, Trulicity, and Viagra

GlobeNewswire

5 months ago

Annovis Files Three New Patents for Combination Therapies Involving Buntanetap, Trulicity, and Viagra

Annovis Bio (NYSE: ANVS) to Present at H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire

6 months ago

Annovis Bio (NYSE: ANVS) to Present at H.C. Wainwright 26th Annual Global Investment Conference

Annovis Bio, Inc. (NYSE:ANVS) surges 24%; retail investors who own 56% shares profited along with insiders

Simply Wall St.

6 months ago

Annovis Bio, Inc. (NYSE:ANVS) surges 24%; retail investors who own 56% shares profited along with insiders

MT Newswires

6 months ago

Annovis Bio Shares Surge After Q2 Net Loss Narrows

Annovis Bio Reports Second Quarter Financial Results and Provides Business Update

GlobeNewswire

6 months ago

Annovis Bio Reports Second Quarter Financial Results and Provides Business Update

Amicus (FOLD) Up as Q2 Earnings & Sales Top, '24 View Updated

Zacks

6 months ago

Amicus (FOLD) Up as Q2 Earnings & Sales Top, '24 View Updated

Xenon (XENE) Q2 Earnings Miss, Pipeline in Focus, Stock Down

Zacks

6 months ago

Xenon (XENE) Q2 Earnings Miss, Pipeline in Focus, Stock Down

Catalyst (CPRX) Rises as Q2 Earnings & Revenues Beat Estimates

Zacks

6 months ago

Catalyst (CPRX) Rises as Q2 Earnings & Revenues Beat Estimates

Acadia (ACAD) Q2 Earnings Beat, Product Sales Drive Revenues

Zacks

7 months ago

Acadia (ACAD) Q2 Earnings Beat, Product Sales Drive Revenues

Zoetis (ZTS) Q2 Earnings & Revenues Beat, '24 Outlook Raised

Zacks

7 months ago

Zoetis (ZTS) Q2 Earnings & Revenues Beat, '24 Outlook Raised

Annovis’ Lead Compound Enhances Cognition Synergistically with GLP-1 Agonist

GlobeNewswire

7 months ago

Annovis’ Lead Compound Enhances Cognition Synergistically with GLP-1 Agonist

IBN Announces Latest Episode of The Bell2Bell Podcast Featuring Annovis Bio CEO Dr. Maria Maccecchini, Live from AAIC 2024

GlobeNewswire

7 months ago

IBN Announces Latest Episode of The Bell2Bell Podcast Featuring Annovis Bio CEO Dr. Maria Maccecchini, Live from AAIC 2024

Viking (VKTX) Q2 Earnings Beat, Stock Up on Pipeline Updates

Zacks

7 months ago

Viking (VKTX) Q2 Earnings Beat, Stock Up on Pipeline Updates

Annovis Bio Secures U.S. Patent for Treatment of Acute Traumatic Brain Injury with Buntanetap

GlobeNewswire

7 months ago

Annovis Bio Secures U.S. Patent for Treatment of Acute Traumatic Brain Injury with Buntanetap

MT Newswires

7 months ago

Annovis Bio Says US FDA Approved Use of Neurodegeneration Drug Buntanetap in Crystalline Form

Annovis Bio Receives FDA Approval to Transition to New Crystal Form of Buntanetap

GlobeNewswire

7 months ago

Annovis Bio Receives FDA Approval to Transition to New Crystal Form of Buntanetap

Pacira (PCRX) Rises on Proposed Exparel Reimbursement Plan

Zacks

7 months ago

Pacira (PCRX) Rises on Proposed Exparel Reimbursement Plan

Brookdale Senior (BKD) Q2 Occupancy Jumps, Growth Trend Persists

Zacks

7 months ago

Brookdale Senior (BKD) Q2 Occupancy Jumps, Growth Trend Persists

Adicet (ACET) Up as Kidney Cancer Drug Gets FDA's Fast Track Tag

Zacks

7 months ago

Adicet (ACET) Up as Kidney Cancer Drug Gets FDA's Fast Track Tag

Annovis Bio Welcomes Four New Executives to Strengthen Leadership Team

GlobeNewswire

7 months ago

Annovis Bio Welcomes Four New Executives to Strengthen Leadership Team

Annovis stock swells after Phase III Parkinson’s subgroup success

Clinical Trials Arena

8 months ago

Annovis stock swells after Phase III Parkinson’s subgroup success

Annovis Bio shares dip on phase III Parkinson's trial data

Yahoo Finance Video

8 months ago

Annovis Bio shares dip on phase III Parkinson's trial data

Annovis (ANVS) Up as Its Lead Candidate Meets Goals in PD Study

Zacks

8 months ago

Annovis (ANVS) Up as Its Lead Candidate Meets Goals in PD Study

MT Newswires

8 months ago

Annovis Shares Rise After Study Shows Effectiveness of Parkinson's Treatment Candidate

Annovis Bio Announces New Data from Phase III Parkinson’s Study Highlighting Improvements in Unified Parkinson's Disease Rating Scale (MDS-UPDRS) and Cognition after Treatment with Buntanetap

GlobeNewswire

8 months ago

Annovis Bio Announces New Data from Phase III Parkinson’s Study Highlighting Improvements in Unified Parkinson's Disease Rating Scale (MDS-UPDRS) and Cognition after Treatment with Buntanetap

Merck's (MRK) New Pneumococcal Jab Capvaxive Gets CDC Panel Vote

Zacks

8 months ago

Merck's (MRK) New Pneumococcal Jab Capvaxive Gets CDC Panel Vote

CASI Pharmaceuticals (CASI) Up on Buyout Offer for China Business

Zacks

8 months ago

CASI Pharmaceuticals (CASI) Up on Buyout Offer for China Business

Annovis Bio Files Provisional Patent for New Manufacturing Process of Crystalline Form of Buntanetap

GlobeNewswire

8 months ago

Annovis Bio Files Provisional Patent for New Manufacturing Process of Crystalline Form of Buntanetap

ImmunityBio (IBRX) Gains 17% in the Past Week: Here's Why

Zacks

8 months ago

ImmunityBio (IBRX) Gains 17% in the Past Week: Here's Why

Annovis Bio Files Patent for New Composition of Matter for Buntanetap

GlobeNewswire

8 months ago

Annovis Bio Files Patent for New Composition of Matter for Buntanetap

Annovis Bio Inc. (NYSE: ANVS) Schedules Investor Webcast to Discuss Parkinson’s Disease Data

GlobeNewswire

8 months ago

Annovis Bio Inc. (NYSE: ANVS) Schedules Investor Webcast to Discuss Parkinson’s Disease Data

Annovis Bio Highlights New Alzheimer’s Data at the Alzheimer’s Association International Conference® 2024

GlobeNewswire

8 months ago

Annovis Bio Highlights New Alzheimer’s Data at the Alzheimer’s Association International Conference® 2024

Annovis Bio’s Buntanetap Found Safe and Effective in High-Risk Alzheimer's Patients

GlobeNewswire

8 months ago

Annovis Bio’s Buntanetap Found Safe and Effective in High-Risk Alzheimer's Patients

NexTech Solutions Has Agreed to Acquire Rome Research Corporation to Expand Service Offerings and Enhance Mission Support Capabilities

PR Newswire

8 months ago

NexTech Solutions Has Agreed to Acquire Rome Research Corporation to Expand Service Offerings and Enhance Mission Support Capabilities

Business Wire

8 months ago

Form 8.3 - International Distribution Services plc

Business Wire

8 months ago

Form 8.3 - Darktrace plc

US Supreme Court rejects Kroger challenge to Grubhub trademark win

Reuters

8 months ago

US Supreme Court rejects Kroger challenge to Grubhub trademark win

Dow Jones Falls As AMD Slides On Downgrade; Nvidia Stock Split Takes Effect

Investor's Business Daily

8 months ago

Dow Jones Falls As AMD Slides On Downgrade; Nvidia Stock Split Takes Effect

GoldATM Supports Growing Consumer Demand for Gold Purchase with New ATMs in North Carolina

Business Wire

8 months ago

GoldATM Supports Growing Consumer Demand for Gold Purchase with New ATMs in North Carolina

GlobeNewswire

8 months ago

Middlefield Canadian Income PCC: Net Asset Value(s)

Business Wire

8 months ago

Form 8.3 - International Paper Company

Annovis Bio Inc. (NYSE: ANVS) Schedules Investor Webcast

GlobeNewswire

9 months ago

Annovis Bio Inc. (NYSE: ANVS) Schedules Investor Webcast

Wall Street Analysts Think Annovis Bio (ANVS) Could Surge 359.53%: Read This Before Placing a Bet

Zacks

9 months ago

Wall Street Analysts Think Annovis Bio (ANVS) Could Surge 359.53%: Read This Before Placing a Bet

Verastem (VSTM) Up on Upbeat Early Pancreatic Cancer Study Data

Zacks

9 months ago

Verastem (VSTM) Up on Upbeat Early Pancreatic Cancer Study Data

Bicycle Therapeutics (BCYC) Up as PIPE Funding Set to Make $555M

Zacks

9 months ago

Bicycle Therapeutics (BCYC) Up as PIPE Funding Set to Make $555M

Deciphera's (DCPH) Shares Surge 74.3% in a Month: Here's Why

Zacks

9 months ago

Deciphera's (DCPH) Shares Surge 74.3% in a Month: Here's Why

Annovis Announces New Publication in a Peer-Reviewed Journal

GlobeNewswire

9 months ago

Annovis Announces New Publication in a Peer-Reviewed Journal

Amgen's (AMGN) Tarlatamab Receives FDA Approval for SCLC

Zacks

9 months ago

Amgen's (AMGN) Tarlatamab Receives FDA Approval for SCLC

Kodiak (KOD) Q1 Loss Narrower Than Expected, Pipeline in Focus

Zacks

9 months ago

Kodiak (KOD) Q1 Loss Narrower Than Expected, Pipeline in Focus

Annovis Bio Provides Corporate Updates and Announces First Quarter 2024 Financial Results

GlobeNewswire

9 months ago

Annovis Bio Provides Corporate Updates and Announces First Quarter 2024 Financial Results

Amicus (FOLD) Q1 Earnings Top, Sales Lag, '24 Outlook Updated

Zacks

9 months ago

Amicus (FOLD) Q1 Earnings Top, Sales Lag, '24 Outlook Updated

Xenon (XENE) Q1 Earnings Beat Estimates, Pipeline in Focus

Zacks

9 months ago

Xenon (XENE) Q1 Earnings Beat Estimates, Pipeline in Focus

Catalyst (CPRX) Q1 Earnings Beat, Firdapse Sales Drive Revenues

Zacks

9 months ago

Catalyst (CPRX) Q1 Earnings Beat, Firdapse Sales Drive Revenues

Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson’s Disease

GlobeNewswire

9 months ago

Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson’s Disease

Acadia (ACAD) Q1 Earnings Surpass Estimates, Revenues Miss

Zacks

9 months ago

Acadia (ACAD) Q1 Earnings Surpass Estimates, Revenues Miss

Intra-Cellular (ITCI) Q1 Earnings and Sales Beat Estimates

Zacks

9 months ago

Intra-Cellular (ITCI) Q1 Earnings and Sales Beat Estimates

Pacira (PCRX) Q1 Earnings Miss, Exparel Sales Drive Revenues

Zacks

9 months ago

Pacira (PCRX) Q1 Earnings Miss, Exparel Sales Drive Revenues

Apellis' (APLS) Q1 Earnings Match Estimates, Revenues Beat

Zacks

10 months ago

Apellis' (APLS) Q1 Earnings Match Estimates, Revenues Beat

Annovis Bio CEO Maria Maccecchini Issues Letter to Stockholders

GlobeNewswire

10 months ago

Annovis Bio CEO Maria Maccecchini Issues Letter to Stockholders

Blueprint (BPMC) Q1 Earnings and Revenues Beat, Stock Rises

Zacks

10 months ago

Blueprint (BPMC) Q1 Earnings and Revenues Beat, Stock Rises

Zoetis (ZTS) Q1 Earnings and Revenues Surpass Estimates

Zacks

10 months ago

Zoetis (ZTS) Q1 Earnings and Revenues Surpass Estimates

Novo Nordisk (NVO) Q1 Earnings Beat, GLP-1 Drugs Boost Sales

Zacks

10 months ago

Novo Nordisk (NVO) Q1 Earnings Beat, GLP-1 Drugs Boost Sales

MT Newswires

10 months ago

Canaccord Genuity Cuts Price Target on Annovis Bio to $26 From $36, Maintains Buy Rating

MT Newswires

10 months ago

Top Midday Decliners

MT Newswires

10 months ago

Annovis Bio Shares Tumble After Drug Candidate Buntanetap for Alzheimer's Misses Efficacy Endpoint in Phase 2/3 Study

Reuters

10 months ago

UPDATE 2-Annovis tumbles as Alzheimer's treatment misses in mid-stage study

Reuters

10 months ago

CORRECTED- Annovis Bio fails to meet main goal of mid-stage Alzheimer's treatment trial

Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer’s Disease

GlobeNewswire

10 months ago

Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer’s Disease

Wall Street Analysts Believe Annovis Bio (ANVS) Could Rally 197.98%: Here's is How to Trade

Zacks

10 months ago

Wall Street Analysts Believe Annovis Bio (ANVS) Could Rally 197.98%: Here's is How to Trade

Share on Social Networks: